Funding for this research was provided by:
National Institute of General Medical Science (P20GM121301, P30 GM106391)
National Institutes of Health (P20GM121301, U54GM115516)
American Cancer Society (IRG-16-191-33)
National Institute of Diabetes and Digestive and Kidney Diseases (R24 DK092759-01)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30 AR066261)
Article History
Received: 1 April 2019
Accepted: 16 September 2019
First Online: 29 October 2019
Ethics approval and consent to participate
: The data reproduced from Boucher et al. 2018 (Boucher JM, Robich M, Scott SS, Yang X, Ryzhova L, Turner JE, Pinz I, Liaw L. Rab27a regulates human perivascular adipose progenitor cell differentiation. Cardiovascular Drugs and Therapy: PVAT Biology 2018, 32(5):519–530) utilized human tissue that was procured via our Maine Medical Center Biobank, which provides de-identified samples. This study was reviewed and deemed exempt by our Maine Medical Center Institutional Review Board. The BioBank protocols are in accordance with the ethical standards of our institution and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individuals for de-identified use of their samples for research purposes. Consent to reproduce data from Boucher et al. 2018 in this review was obtained from Springer Nature and the senior author of the paper, Dr. Lucy Liaw. The data from Fig.InternalRef removedd was reprinted by permission from RightsLink: Springer Nature, <i>Cardiovascular Drugs and Therapy</i>, Boucher et al. 2018.
: Not applicable.
: The Reagan laboratory was also supported by Union Chemique Belge, but that contractual funding had no effect on the content within this review article. The Liaw lab (senior author of Boucher et al. 2018) did not receive funding from Union Chemique Belge or other funding sources that would warrant the declaration of a competing interest.